If they mentioned LL or Cytodyn without an announcement and/or a press release i doubt if this story is true. they would speak more at a high level on the types of drugs they are interested in to add to their portfolio. ive been on many analyst calls and we never would even mention the name of a company we were interested in, only the direction we wanted to take the company..you dont talk about a company you are going to partner with or buy before something is actually signed